Latest Breaking News On - உமேஷ் ஷாலிகிராம் - Page 1 : comparemela.com

Date Time Promising malaria vaccine enters final stage of clinical testing in West Africa R21/Matrix-M becomes the second malaria vaccine candidate ever to start a phase III licensure trial This builds on the recent finding of high level efficacy of this vaccine in a phase IIb trial in children in Burkina Faso, published today in The Lancet The first phase III trial doses were administered by the team at the Malaria Research and Training Centre, Bamako, Mali, one of five trial sites across West and East Africa The malaria vaccine was designed at the Jenner Institute, University of Oxford, who have partnered with the Serum Institute of India for commercial development

Burkina fasoRegion du centre ouestUmesh shaligramHalidou tintoJean bosco ouedraogoAlassane dickoAdrian hillAbdoulaye djimdSerum institute of india pvt ltdUniversity of oxfordUniversity of scienceJenner instituteTraining centreHead of the bougouni clinical research unitMalaria researchInstitute of sciences